Your browser doesn't support javascript.
loading
Repurposing the ß3-Adrenergic Receptor Agonist Mirabegron in Patients With Structural Cardiac Disease: The Beta3-LVH Phase 2b Randomized Clinical Trial.
Balligand, Jean-Luc; Brito, Dulce; Brosteanu, Oana; Casadei, Barbara; Depoix, Christophe; Edelmann, Frank; Ferreira, Vanessa; Filippatos, Gerasimos; Gerber, Bernhard; Gruson, Damien; Hasenclever, Dirk; Hellenkamp, Kristian; Ikonomidis, Ignatios; Krakowiak, Bartosz; Lhommel, Renaud; Mahmod, Masliza; Neubauer, Stefan; Persu, Alexandre; Piechnik, Stefan; Pieske, Burkert; Pieske-Kraigher, Elisabeth; Pinto, Fausto; Ponikowski, Piotr; Senni, Michele; Trochu, Jean-Noël; Van Overstraeten, Nancy; Wachter, Rolf; Pouleur, Anne-Catherine.
Afiliação
  • Balligand JL; Institut de Recherche Expérimentale et Clinique, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium.
  • Brito D; Department of Cardiology, Centro Hospitalar Universitário Lisboa Norte, Lisboa, Portugal.
  • Brosteanu O; Centro Académico de Medicina de Lisboa, Universidade de Lisboa, Lisboa, Portugal.
  • Casadei B; Faculdade de Medicina, Centro Cardiovascular, Universidade de Lisboa, Lisboa, Portugal.
  • Depoix C; Clinical Trial Centre Leipzig, Universität Leipzig, Leipzig, Germany.
  • Edelmann F; Division of Cardiovascular Medicine, Radcliffe Department of Medicine, British Heart Foundation Centre of Research Excellence, University of Oxford, Oxford, United Kingdom.
  • Ferreira V; National Institute of Health Research Oxford Biomedical Research Centre, John Radcliffe Hospital, Oxford, United Kingdom.
  • Filippatos G; Institut de Recherche Expérimentale et Clinique, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium.
  • Gerber B; Department of Cardiology, German Centre for Cardiovascular Research, Charité University Campus Virchow, Berlin, Germany.
  • Gruson D; Radcliffe Department of Medicine, Oxford Centre for Clinical Magnetic Resonance Research, University of Oxford, Oxford, United Kingdom.
  • Hasenclever D; Department of Cardiology, School of Medicine, National and Kapodistrian University of Athens, Attikon University Hospital, Athens, Greece.
  • Hellenkamp K; Institut de Recherche Expérimentale et Clinique, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium.
  • Ikonomidis I; Institut de Recherche Expérimentale et Clinique, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium.
  • Krakowiak B; Institute for Medical Informatics, Statistics, and Epidemiology, Universität Leipzig, Leipzig, Germany.
  • Lhommel R; Department of Cardiology and Pneumology, German Centre for Cardiovascular Research, Universitätsmedizin Göttingen, Göttingen, Germany.
  • Mahmod M; Department of Cardiology, School of Medicine, National and Kapodistrian University of Athens, Attikon University Hospital, Athens, Greece.
  • Neubauer S; Department of Cardiology, Centre for Heart Diseases, Clinical Military Hospital, Wroclaw Medical University, Wroclaw, Poland.
  • Persu A; Institut de Recherche Expérimentale et Clinique, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium.
  • Piechnik S; Radcliffe Department of Medicine, Oxford Centre for Clinical Magnetic Resonance Research, University of Oxford, Oxford, United Kingdom.
  • Pieske B; Radcliffe Department of Medicine, Oxford Centre for Clinical Magnetic Resonance Research, University of Oxford, Oxford, United Kingdom.
  • Pieske-Kraigher E; Institut de Recherche Expérimentale et Clinique, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium.
  • Pinto F; Radcliffe Department of Medicine, Oxford Centre for Clinical Magnetic Resonance Research, University of Oxford, Oxford, United Kingdom.
  • Ponikowski P; Department of Cardiology, German Centre for Cardiovascular Research, Charité University Campus Virchow, Berlin, Germany.
  • Senni M; Department of Cardiology, German Centre for Cardiovascular Research, Charité University Campus Virchow, Berlin, Germany.
  • Trochu JN; Department of Cardiology, Centro Hospitalar Universitário Lisboa Norte, Lisboa, Portugal.
  • Van Overstraeten N; Centro Académico de Medicina de Lisboa, Universidade de Lisboa, Lisboa, Portugal.
  • Wachter R; Faculdade de Medicina, Centro Cardiovascular, Universidade de Lisboa, Lisboa, Portugal.
  • Pouleur AC; Department of Cardiology, Centre for Heart Diseases, Clinical Military Hospital, Wroclaw Medical University, Wroclaw, Poland.
JAMA Cardiol ; 8(11): 1031-1040, 2023 11 01.
Article em En | MEDLINE | ID: mdl-37728907
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Insuficiência Cardíaca Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Insuficiência Cardíaca Idioma: En Ano de publicação: 2023 Tipo de documento: Article